Table 2 Number of observed second primary cancers (Obs) following breast cancer, diagnosed between 1958 and 2000, standardised incidence ratios (SIRs), and 95% confidence interval (CI) for second primary malignancy according to age at breast cancer diagnosis
Age at breast cancer diagnosis | |||||||
|---|---|---|---|---|---|---|---|
<50 years | ⩾50 years | ||||||
Second primary cancer site | Obs | SIR | 95% CI | Obs | SIR | 95% CI | Ratio |
Oesophagus | 20 | 2.54 | (1.55–3.78) | 96 | 1.38 | (1.12–1.67) | 1.84* |
Stomach | 97 | 2.18 | (1.77–2.63) | 589 | 1.32 | (1.22–1.43) | 1.65* |
Colorectum | 278 | 1.38 | (1.23–1.58) | 1645 | 1.12 | (1.06–1.17) | 1.24* |
Pancreas | 74 | 1.60 | (1.26–1.99) | 397 | 1.06 | (0.96–1.16) | 1.51* |
Lung | 235 | 2.35 | (2.06–2.66) | 482 | 1.14 | (1.04–1.24) | 2.07* |
Endometrium | 183 | 1.29 | (1.11–1.49) | 823 | 1.61 | (1.50–1.72) | 0.80* |
Ovary | 247 | 1.97 | (1.73–2.22) | 465 | 1.08 | (0.98–1.18) | 1.82* |
Kidney | 74 | 1.50 | (1.18–1.86) | 369 | 1.28 | (1.15–1.41) | 1.17 |
Melanoma | 91 | 1.32 | (1.06–1.61) | 269 | 1.25 | (1.10–1.40) | 1.06 |
Nervous system | 89 | 1.25 | (1.00–1.52) | 278 | 1.14 | (1.01–1.27) | 1.10 |
Thyroid | 51 | 2.21 | (1.65–2.86) | 113 | 1.36 | (1.12–1.63) | 1.62* |
Endocrine glands | 75 | 1.36 | (1.07–1.68) | 195 | 1.01 | (0.87–1.15) | 1.35* |
Connective tissue | 40 | 3.27 | (2.33–4.36) | 89 | 1.48 | (1.19–1.80) | 2.21* |
Thorax and upper limbs | 19 | 8.02 | (4.82–12.03) | 42 | 3.46 | (2.49–4.58) | 2.32* |
Non-Hodgkin's lymphoma | 77 | 1.51 | (1.19–1.87) | 313 | 1.06 | (0.95–1.19) | 1.42* |
Leukaemia | 61 | 1.81 | (1.38–2.29) | 282 | 1.30 | (1.15–1.46) | 1.39* |
Acute lymphatic leukaemia | 2 | 1.20 | (0.14–3.45) | 20 | 2.19 | (1.34–3.26) | 0.55 |
Chronic lymphatic leukaemia | 14 | 1.15 | (0.63–1.84) | 87 | 0.96 | (0.77–1.17) | 1.21 |
Acute myeloid leukaemia | 22 | 1.97 | (1.23–2.88) | 91 | 1.46 | (1.17–1.77) | 1.35 |
Chronic myeloid leukaemia | 13 | 2.89 | (1.53–4.67) | 33 | 1.56 | (1.08–2.14) | 1.85 |
All the above sites | 1692 | 1.64 | (1.56–1.72) | 6405 | 1.20 | (1.17–1.23) | 1.36* |